1-2 of 2
Ludger Grosse-Hovest
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B144: Reduction of minimal residual disease in pediatric B-precursor acute lymphoblastic leukemia by an Fc-optimized CD19 antibody

Ursula Joerdis Eva Seidel, Ludger Grosse-Hovest, Patrick Schlegel, Martin Hofmann, Friedhelm R. Schuster, Roland Meisel, Kai-Erik Witte, Steffen Aulwurm, Elwira Pyz, Hans-Georg Rammensee, Gundram Jung, Rupert Handgretinger, Peter Lang
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): B144.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B144
Published: 03 January 2016
View article titled, Abstract B144: Reduction of minimal residual disease in pediatric B-precursor acute lymphoblastic leukemia by an Fc-optimized CD19 antibody
Journal Articles

Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity

Karoline Laske, Yuriy V. Shebzukhov, Ludger Grosse-Hovest, Dmitry V. Kuprash, Svetlana V. Khlgatian, Ekaterina P. Koroleva, Alexey Y. Sazykin, Dmitry N. Penkov, Pavel V. Belousov, Stefan Stevanović, Verona Vass, Steffen Walter, David Eisel, Barbara D. Schmid-Horch, Sergei A. Nedospasov, Hans-Georg Rammensee, Cécile Gouttefangeas
Journal: Cancer Immunology Research
Cancer Immunol Res (2013) 1 (3): 190–200.
https://doi.org/10.1158/2326-6066.CIR-13-0079
Published: 08 September 2013
View article titled, Alternative Variants of Human <em>HYDIN</em> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity
Open the PDF for Alternative Variants of Human <em>HYDIN</em> Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity in another window
Includes: Supplementary data